ABVC BioPharma, Inc. (ABVC) vs Kyntra Bio, Inc. (KYNB)
A side-by-side comparison of ABVC BioPharma, Inc. and Kyntra Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABVC
ABVC BioPharma, Inc.
$0.97HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
KYNB
Kyntra Bio, Inc.
$6.10HealthcareDelayed quote: Oct 6, 2026, 10:01 AM EDT
Total return — ABVC vs KYNB
growth of $100 · dividends reinvested · last 10yABVC -99.7% (-44.6%/yr)KYNB -98.8% (-35.7%/yr)KYNB compounded faster over this window
ABVC KYNB
ABVC vs KYNB: by the numbers
- •ABVC is the larger company ($25M vs $25M market cap).
- •KYNB is profitable (3967.77% net margin) while ABVC runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ABVC | KYNB |
|---|---|---|
| P/S ratio | N/A | 5.35 |
| P/B ratio | 2.44 | N/A |
Profitability
| Metric | ABVC | KYNB |
|---|---|---|
| Gross margin | 0.00% | 91.37% |
| Operating margin | 0.00% | -712.66% |
| Net margin | 0.00% | 3967.77% |
| ROE | -76.82% | N/A |
| ROIC | -53.34% | -78.16% |
Growth (annualized)
| Metric | ABVC | KYNB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -51.49% |
| Total return CAGR (5Y) | -46.33% | -52.67% |
Frequently asked
- Is ABVC or KYNB more profitable?
- KYNB runs the higher net margin — ABVC at 0.00% versus KYNB at 3967.77%.
- How have ABVC and KYNB total returns compared?
- Over the past 10 years, ABVC delivered -44.60% and KYNB delivered -35.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.